$AEO

Sable David M. sold $100K of AEO

Sable David M. sold 5,779 shares of AMERICAN EAGLE OUTFITTERS INC (AEO) at $17.23 on 2026-07-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Sable David M.
Published Jul 21, 2026, 8:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 21, 2026, 8:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AEO
Neutral
high confidence
Mentioned
$AEO
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEONeutralLow
01

Why it matters

The disclosed open-market sale is pre-arranged under a Rule 10b5-1 plan, which typically limits the informational value of the transaction for forecasting near-term performance.

02

Market read

Traders may log the transaction for sentiment monitoring, but it does not introduce new operational, financial, or regulatory information.

03

What to watch

The article does not disclose motivations, tax considerations, or whether other insiders are selling/buying around the same window; without that context, signal quality is low.

Relevance 2/10Novelty 2/10Timing: Filed after-hours on 2026-07-21, reflecting a sale dated 2026-07-17.

Background

The article is an SEC Form 4 insider transaction for American Eagle Outfitters (AEO), reported by director Sable David M.

Company-level read

Ticker impact

$AEONeutralHigh confidence
Context

Form 4 shows director Sable David M sold 5,779 shares of AEO on 2026-07-17 at $17.23, totaling about $99.6K.

Expected impact

Likely negligible immediate price impact; any effect is more about sentiment than new company information.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and the disclosed value is modest versus typical market-moving thresholds.

Market effects

No sector read-through; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider sales can coincide with periods of reduced confidence, so traders may still watch for follow-on selling patterns.

Key entities

  • AEO

    American Eagle Outfitters Inc., the company whose director reported an open-market sale on Form 4.

  • Sable David M.

    Director who sold 5,779 shares on 2026-07-17 under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEOMed

BMO raises American Eagle Outfitters stock price target on Aerie momentum

BMO Capital raised its price target on American Eagle Outfitters (NYSE:AEO) to $20 from $18, citing strong Aerie brand momentum and improved women's bottoms sales. The stock trades at $17.41 with a P/E ratio of 8.93. BMO expects upside to Q4 gross margin guidance due to lower tariff rates. AEO reported Q2 earnings of $0.79 per share on $1.38 billion revenue, beating estimates. TD Cowen cut its target to $16, while UBS lowered its target to $27 but maintained a Buy rating.

$AEOHighAI 8/10

Earnings Guidance Lift Could Change The Bull Case For American Eagle Outfitters (AEO)?

American Eagle Outfitters (AEO) reported Q2 2026 sales of $1.38B, net income of $134.08M, and EPS of $0.80. The company issued Q3 and full-year 2026 operating income guidance of $110M-$115M and $540M-$550M, respectively. Analysts highlight execution around inventory, markdowns, and digital productivity as key catalysts, while noting risks from consumer caution and cost pressures. The company declared a quarterly dividend of $0.125 per share.

$AEOMedAI 8/10

American Eagle Goes on Sale: Is It Time to Buy?

American Eagle reported Q2 revenue of $1.4B, up 8%, beating expectations. Aerie and OFFLINE segments drove growth, while the core brand faced challenges. Margins were impacted by tariff refunds and markdowns. Analysts trimmed price targets, but the consensus suggests 35% upside. Institutional investors own 98% of the float, showing bullish signs. The core brand's turnaround is a key risk.

$AAPLMed

Apple, Compass Pathways, Aritzia and more analyst calls of the week

Dell shares rose 11% to a record high after RBC initiated coverage with an Outperform rating and $640 target, citing strong AI and PC demand. Apple shares gained 3.1% after unveiling its first foldable iPhone, the iPhone Duo, priced at $1,999 and above. AstraZeneca's shares remained flat despite mixed analyst views on its drug tozorakimab. Compass Pathways shares climbed 4% on positive Phase III study data for its psilocybin treatment.